Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.
Antisera specific for six regions of the v- abl protein were used to serologically characterize the Abelson murine leukemia virus tyrosine kinase. Chemically synthesized peptides corresponding to the predicted v- abl protein sequence and larger regions of the v- abl protein expressed as fusion proteins in bacteria were used as immunogens. The specificity of each antiserum was confirmed by immunoprecipitation analysis with defined deletion mutants of Abelson murine leukemia virus. Several of these v- abl -specific antisera display much higher titers and avidities than serum harvested from mice bearing Abelson murine leukemia virus-induced tumors, previously the only source of anti- abl -specific serum. Two antisera were found to block the in vitro autophosphorylation of the v- abl protein as well as its ability to phosphorylate a peptide substrate. Examination of the sites against which the kinase-blocking antisera were prepared revealed that both are in close proximity to the in vivo sites of tyrosine phosphorylation, which fall within the region of high homology with v-src and other tyrosine kinases. Antisera directed against other regions of v- abl did not inhibit kinase activity.
D000011:Abelson murine leukemia virus / Q000235:genetics; D000818:Animals; D004279:DNA, Viral / Q000032:analysis; D007106:Immune Sera; D051379:Mice; D010766:Phosphorylation; D010957:Plasmids; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases; D014759:Viral Envelope Proteins / Q000276:immunology; D014760:Viral Fusion Proteins; D014764:Viral Proteins / Q000276:immunology*
D004279:DNA, Viral; D007106:Immune Sera; D047428:Protein Kinase Inhibitors; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins; D014764:Viral Proteins; D011505:Protein-Tyrosine Kinases